PET (positron emission tomography) beats SPECT (single photon emission computed tomography) as heart risk diagnostic
This article was originally published in Clinica
Positron emission tomography (PET) scanning is more accurate, less invasive and more cost effective than single photon emission computed tomography (SPECT) imaging when used as the first tool to diagnose cardiac vessel blockages. So suggest the results of a trial conducted at the State University of New York, published in the July edition of the Journal of Nuclear Medicine. Lead researcher Dr Michael Merhige, clinical associate professor of nuclear medicine at the university, said that the researchers found a more than 50% decrease in the use of invasive coronary arteriography and coronary artery bypass grafting when PET was used as the first-line test.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.